2nd International Conference onStem Cells and Regenerative Medicine

MD, CEO and Founder of Biotechnology and Regenerative Medicine at REGENERAGE® Elite Clinic (www.regenerage.clinic). Master in cellular and molecular biology by ESNECA. Advance Fellow by the American Board of Anti-Aging and Regenerative Medicine (A4M).

Editor In Chief of the Journal of Regenerative Biology and Medicine (https://maplespub.com/journal/ Journal-of-Regenerative-Biology-and-Medicinehttps://maplespub.com/journal/Journal-of-Regenerative- Biology-and-Medicine). Executive Chairman WAMS Americas Division (https://wams.online/about-us/

faculty/). Visiting Scholar at University of North Carolina at Chapel Hill (Dermatology). Fellow in Stem Cell Medicine by the American Academy of Anti-Aging Medicine and University of South Florida.

Dr Benetti was graduate in 1971 in Rosario Argentina after complete his formation in Cardiac Surgery He perform 5 original thecniques in Cardiac Surgery 3 on the Coronary Surgery and 2 on the Valve Surgery He perform from the first time on the world a MIDCAB operation in 1994 He hold 30 USA patents of inventions In 1997 he performed the first ambulatory coronary surgery on the world througth the MINI OPCAB thecnique In March 2003 he performed the first Stem Cell injection with and OPCAB operation he developted the thecnique In 2005 he did the only serie on the world were trasplanted Fetal Stem Cells in terminal Heart Failure patients He hold many awards Recently was nominate in the Old Parliament in Athens Greece one of the 7 Wise Man of the World for his contribution He trained Surgeons througth his Foundation in 45 Countries

I am a general physician and diabetologist with 20 years of experience,10 years of experience in telemedicine only.Iam one of the future 50 clinical leaders in telehealth recognised by HIMSS globally. Ambassador telemedicine today karnataka India chapter and Ambassador Global telehealth exchange.Iam also the director of BENFA health care program through which I have started a free telemedicine helpline to help people in need .Iam also the director of women empowerment in world peace organization Karnataka chapter . During covid waves I volunteered with various groups like Project stepone, ERT, mercy mission and many more and have teletriaged and treated more than 7000 plus covid patients on a probono basis
For this and for my contribution in digital health or telemedicine I have received around 20 awards so far .I have been featured in a book called Dream big as one of the 20 women achievers in Karnataka have also been listed by fox story as one of the 100 influential Indians Was featured in a Cannadian French paper called Le- Devoir .
Also featured in a book called Top 100 women of the future volume 2 which is released in Miami .It features ladies from digital space all over the globe including NASA .Iam the only residential Indian in the list .

He holds a degree in Medicine from the Federal University of Grande Dourados (2006), a master's degree in Health and Development in the Midwest Region from the Federal University of Mato Grosso do Sul (2016) and a PhD in Health and Development in the Midwest Region from the Federal University of Mato Grosso do Sul (2022). He is currently a cooperative physician - Unimed Campo Grande MS - Medical Work Cooperative and urology service at the Maria Aparecida Pedrossian University Hospital. He has experience in the area urology, lithiasis, voiding dysfunction, oncology and quality of life.

John M. Baust, Ph.D., is pioneer in cryopreservation. His research on the molecular mechanisms of cell death and low temperature stress, focusing on signal transduction and apoptosis, has advanced of the field of cryobiology into the molecular biological era. Dr. Baust discovered and characterized the phenomena of cryopreservation-induced delayed-onset cell death. As an entrepreneur, Dr. Baust has founded/ been on the founding team of 5 biotech and medtech companies.  He has been involved with the developed and commercialization of several products including CryoStor and HTS-FRS (BioLife Solutions, Inc). In addition to these activities, Dr. Baust helped establish, and serves on the editorial board of, the journal Biopreservation and Biobanking as well as a reviewer for several other scientific journals including Cryobiology. Dr. Baust is currently the President Elect for the Society for Cryobiology. Dr. Baust completed his studies at Cornell University, Binghamton University and Harvard Medical School. 

Laila M. Montaser is distinguished Prof. of Clinical Pathology. Chair, Stem Cell, Regenerative Medicine, Nanotechnology and Tissue Engineering (SRNT) Research Group. She served as the Chair, Founder leader of Clinical Pathology Department at Menoufia Faculty of Medicine. She supervised more than 47 M. Sc. theses and 13 MD theses. She has more than 237 International publications in world peer-reviewed journals and global conferences. Montaser has given more than 100 keynote presentations on four continents. She gained six Awards: - Nishan Al-Kamal and Certificate of Excellence for the best pupil in Alexandria Governorate from Egyptian Feast of Science. - Medal of Merit for the ideal Doctor from Egyptian Medical Syndicate in 1986, 1998, 2002, & 2024. – A certificate of thanks and appreciation honored at the Menoufia University’s forty-seventh annual anniversary.  During the COVID-19 phase, she presented sixty webinars from her home office, earning her fifty four certificates of appreciation.

Dr. Mahajan completed his master's in general surgery from Marathwada University, Maharashtra, and went on to pursue a Diploma in Urology at the University of Vienna, Austria. In a career-changing move, after three decades of being a successful general and Urosurgeon, he started his brainchild - StemRx Bioscience Solutions Pvt. Ltd. in the year 2011. This was to focus on in-depth research in the field of Regenerative Medicine and Cell Based Therapy which he believes is the solution to address the limitations of conventional therapeutic modalities. To this effect, he underwent and continues to undergo intensive training in the United States. He has devised personalized treatment protocols in cell-based therapy for more than 100+ health conditions. Dr Mahajan has published 26 research articles in International and National Journals. He has a patent for Avascular Necrosis and is on the board for reviewing scholarly articles for various international journals. Dr Mahajan has received many international awards for his pioneering research work in regenerative medicine.

Susanna Uusmaa is a biomedical scientist with broad expertise in Medical Sciences and International Business. Holding an MSBS degree, she is result-driven to integrate modern smart technologies into making substantive contributions to the biomedical sector. Having conducted research in neuroscience and oncology and having proudly graduated from Tallinn University of Technology (TALTECH) and Tallinn University School of Natural Sciences and Health, Uusmaa takes an evidence-based approach to her professional objectives and also to her endeavors as a passionate healthy lifestyle entrepreneur. With a background in biomolecular and medical sciences, she has recently co-founded Quantum Brain Research Institute to support the development of neuroscientific research for neurocritical treatment applications through instructive programs in mental health assessment and management. In collaboration with the Luxembourg Institute of Health and Luxembourg Centre for Systems Biomedicine, she developed a complete standard operating procedure for differentiating and generating fully functional glial cells from induced pluripotent stem cells (iPSCs) in only 30 days. Moreover, she holds over 6 years of hard-working experience in business operations and relationship building in more than 5 countries around the globe, having created and nurtured mutually beneficial partnerships, enhanced workflow efficiency, and contributed to the growth of several initiatives with substantial savings. Ms. Uusmaa’s biomedical undertakings have positioned her as an MSBS able to become an active contributor also to the longevity sector and put her expertise into helping people become their best version of themselves with properly validated and ethical practices. She considers herself lucky to be born in the beautiful Northern European city of Tallinn in Estonia, a UNESCO World Heritage treasure of the Baltic Sea, where women’s rights are valued and where cutting-edge technologies are implemented in e-governance and healthcare. Uusmaa brings strong organizational and unique interpersonal abilities to her scope of action with the ultimate goal of integrating smart and efficient solutions to the biomedical sector and creating awareness of healthy living & healthy aging.

Barbara Barboni is a cell biologist from years addressed the study of reproductive-derived cells’ function. Her scientific expertise has always made use of both theoretical (systems biology) and experimental approaches in vitro and in vivo mainly on preclinical models of regeneration. She has built her university commitment after years of experience in research, evaluation, teaching, and administration in university and ministerial institutions.

De la Parra-Solomon is an entrepreneur focused on Information Technology, Education, and Health. He is creative, results-driven, and has 16+ years of Digital Strategy experience in architecture and implementation. De la Parra-Solomon is the Chief Strategy Officer and Co-Founder of the Quantum Brain Research Institute (www.quantumbrain.institute), a HealthTech initiative established in Tallinn, Estonia focused on Mental Health and Information Technology solutions. He serves as COO and Co-founding Partner at The Solomon Brokerage Firm. He also leads as Vice President of Digital Strategy at Mass Media Division, while being the CEO of De la Parra Mobile Solutions. He is the former Vice President of Strategy and Operations at PetroM Corp and its subdivisions PetroM Logistics and PetroM Pharma, and the former COO & Co-founder at RegenerAge Clinic & RegenerAge Beauty. Mr. De la Parra-Solomon is the former CEO & Founder of Astrum Salud Móvil and its Telemedicine service Astrum Móvil, former Digital Strategy Director & Co-founder at Dr. Jois, BiorganicAging, What Skin Needs/WSN International Pty. Ltd. He also served as a member of the Board of Advisors and is former Chief Marketing Officer at ReAnima Advanced Biosciences and served as Digital Media Director at Bioquark, Inc. He also served as the Latin America Region Manager and Digital Strategy adviser at CardiacSense and is a former CITO & Senior Partner at Cerezo Editores. 

Dr Cho’s main research interests have been focusing on cancer studies to discover biomarkers for cancer diagnosis, treatment prediction and prognostication. As a seasoned researcher, Dr Cho has conducted cancer research in using molecular biology, proteomics, genomics, immunology as well as bioinformatics, his current H-index is 100. Dr. Cho has published more than 600 peer-reviewed papers (Lancet, Lancet Oncology, Annals of Oncology, Lancet Gastroenterology & Hepatology, Advanced Science, Nature Communications, PNAS, Molecular Cancer, Journal of Thoracic Oncology, Journal of the National Cancer Institute, Journal of Extracellular Vesicles, Clinical Cancer Research, Clinical Chemistry, Theranostics, etc.) covering cancer biomarkers, proteomics, non-coding RNA, traditional Chinese medicine, and dozens of books (including “An Omics Perspective on Cancer Research”, “MicroRNAs in Cancer Translational Research”, “Drug Repurposing in Cancer Therapy: Approaches and Applications” and “Supportive Cancer Care with Chinese Medicine”, etc).